These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2598096)

  • 1. [Studies on the persistence of immunity 15 years after revaccination with measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):392-5. PubMed ID: 2598096
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 3. Measles seroepidemiology among adolescents and young adults: response to revaccination.
    Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
    East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 7. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine.
    abu Eldan J; Borćić B; Smerdel S
    Acta Med Croatica; 1991; 45(4-5):297-304. PubMed ID: 1726513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-laboratory indices of children revaccinated against measles].
    Sorokina EA; Bystriakova LV; Sertakova ZL; Terekhova LE
    Tr Inst Im Pastera; 1985; 62():50-4. PubMed ID: 2954276
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Measles immunity and revaccination.
    Balfour HH; Quie PG; Kalis JM
    JAMA; 1976 May; 235(19):2079. PubMed ID: 946524
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimum age for measles immunisation: study of pre- and post-immunization level of HI antibody titres.
    Bhatnagar SK; Mohan M; Kumar P; Balaya S; Prabhakar AK; Bhargava SK
    Indian Pediatr; 1981 Sep; 18(9):625-9. PubMed ID: 6797943
    [No Abstract]   [Full Text] [Related]  

  • 18. [Revaccination against measles].
    Gerike E; Kirchner W; Pöhle W; Tischer A
    Z Gesamte Hyg; 1983 Feb; 29(2):62-5. PubMed ID: 6858258
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of consultative offices on immunoprophylaxis in organizing epidemiologic surveillance of measles].
    Ignatov SA; Radomskaia FS; Makarova EN; Leĭko AP; Itkina EN; Komarevskaia RV
    Vrach Delo; 1990 Jan; (1):121-3. PubMed ID: 2330697
    [No Abstract]   [Full Text] [Related]  

  • 20. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.